首页> 外文期刊>Journal of Zhejiang University. Science, B >Iptakalim, an ATP-sensitive potassium channel opener, confers neuroprotection against cerebral ischemia/reperfusion injury in rats by protecting neurovascular unit cells
【24h】

Iptakalim, an ATP-sensitive potassium channel opener, confers neuroprotection against cerebral ischemia/reperfusion injury in rats by protecting neurovascular unit cells

机译:ATP敏感的钾通道开启者IPTakalim,通过保护神经血管单位细胞来赋予大鼠脑缺血/再灌注损伤的神经保护作用

获取原文
       

摘要

Objective: To investigate the role of iptakalim, an ATP-sensitive potassium channel opener, in transient cerebral ischemia/reperfusion (I/R) injury and its involved mechanisms. Methods: Intraluminal occlusion of middle cerebral artery (MCAO) in a rat model was used to investigate the effect of iptakalim at different time points. Infarct volume was measured by staining with 2,3,5-triphenyltetrazolium chloride, and immunohistochemistry was used to evaluate the expressions of Bcl-2 and Bax. In vitro, neurovascular unit (NVU) cells, including rat primary cortical neurons, astrocytes, and cerebral microvascular endothelial cells, were cultured and underwent oxygen-glucose deprivation (OGD). The protective effect of iptakalim on NVU cells was investigated by cell viability and injury assessments, which were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and release of lactate dehydrogenase. Caspase-3, Bcl-2 and Bax mRNA expressions were evaluated by real-time polymerase chain reaction (PCR). Results: Administration of iptakalim 0 or 1 h after reperfusion significantly reduced infarct volumes, improved neurological scores, and attenuated brain edema after cerebral I/R injury. Iptakalim treatment (0 h after reperfusion) also reduced caspase-3 expression and increased the ratio of Bcl-2 to Bax by immunohistochemistry. Iptakalim inhibited OGD-induced cell death in cultured neurons and astrocytes, and lactate dehydrogenase release from cerebral microvascular endothelial cells. Iptakalim reduced mRNA expression of caspase-3 and increased the ratio of Bcl-2 to Bax in NVU cells. Conclusions: Iptakalim confers neuroprotection against cerebral I/R injury by protecting NVU cells via inhibiting of apoptosis.
机译:目的:探讨IPTAKALIM,ATP敏感钾通道开启器,瞬态脑缺血/再灌注(I / R)损伤及其涉及机制的作用。方法:大鼠模型中脑动脉(MCAO)的管腔内闭塞用于研究不同时间点IPTAKALIM的影响。通过用2,3,5-三苯基四唑鎓氯化物染色来测量梗塞体积,使用免疫组化评估Bcl-2和Bax的表达。体外,神经血管单元(NVU)细胞,包括大鼠原发性皮质神经元,星形胶质细胞和脑微血管内皮细胞,培养并进行氧 - 葡萄糖剥夺(OGD)。通过细胞活力和损伤评估研究了IPTakalim对NVU细胞的保护作用,其通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化铵和乳酸脱氢酶的释放来测量。通过实时聚合酶链反应(PCR)评估Caspase-3,Bcl-2和Bax mRNA表达。结果:再灌注后Iptakalim 0或1小时给药显着降低了梗塞体积,改善神经学评分,并在脑I / R损伤后减毒脑水肿。 IPTAKALIM处理(再灌注后0 H)也降低了Caspase-3表达,并通过免疫组化增加了Bcl-2与Bax的比例。 IPTAKALIM在培养的神经元和星形胶质细胞中抑制OGD诱导的细胞死亡,并从脑微血管内皮细胞中乳酸脱氢酶释放。 Iptakalim降低了Caspase-3的mRNA表达,并增加了NVU细胞中Bcl-2与Bax的比率。结论:IPTAKALIM通过抑制细胞凋亡保护NVU细胞来赋予脑I / R损伤的神经保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号